Cargando…

An In Silico Analysis Reveals an EMT-Associated Gene Signature for Predicting Recurrence of Early-Stage Lung Adenocarcinoma

BACKGROUND: The potential micrometastasis tends to cause recurrence of lung adenocarcinoma (LUAD) after surgical resection and consequently leads to an increase in the mortality risk. Compelling evidence has suggested the underlying mechanisms of tumor metastasis could involve the activation of an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yi, Wong, Fang Cheng, Wang, Di, Kahlert, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133999/ https://www.ncbi.nlm.nih.gov/pubmed/35645555 http://dx.doi.org/10.1177/11769351221100727

Ejemplares similares

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma
por: Wang, Haiqiang, et al.
Publicado: (2022)

A circular RNAs dataset landscape reveals potential signatures for the detection and prognosis of early-stage lung adenocarcinoma
por: Chen, Zhiying, et al.
Publicado: (2021)

A robust prognostic gene expression signature for early stage lung adenocarcinoma
por: Krzystanek, Marcin, et al.
Publicado: (2016)

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma
por: Luo, Jizhuang, et al.
Publicado: (2016)

Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature
por: Basu, Arkaprabha, et al.
Publicado: (2022)

Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma
por: Kammer, Michael N., et al.
Publicado: (2023)

Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature
por: Li, Dan, et al.
Publicado: (2018)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2022)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2022)

Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma
por: Wang, Yibei, et al.
Publicado: (2023)

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
por: Hu, Ankang, et al.
Publicado: (2023)

Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients
por: Sun, Jing, et al.
Publicado: (2020)

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes
por: Liu, Chia-Hsin, et al.
Publicado: (2023)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
por: Dama, Elisa, et al.
Publicado: (2020)

Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
por: Bao, Xuanwen, et al.
Publicado: (2020)

Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma
por: Shimada, Yoshihisa, et al.
Publicado: (2023)

Long Noncoding RNA-LET Suppresses Tumor Growth and EMT in Lung Adenocarcinoma
por: Liu, Bin, et al.
Publicado: (2016)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature
por: Wang, Xiaoxiao, et al.
Publicado: (2019)

Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression
por: Yao, Jiaxi, et al.
Publicado: (2022)

Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Different pathologic types of early stage lung adenocarcinoma have different post‐operative recurrence patterns
por: Liu, Xianping, et al.
Publicado: (2021)

A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
por: Chen, Mingwei, et al.
Publicado: (2017)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature
por: Wang, Zi-Hao, et al.
Publicado: (2022)

Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
por: Devan, Aswathy R., et al.
Publicado: (2023)

DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma
por: Sato, Takashi, et al.
Publicado: (2013)

Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma
por: Sim, Jongmin, et al.
Publicado: (2018)

Stratifin accelerates progression of lung adenocarcinoma at an early stage
por: Shiba-Ishii, Aya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0t3o3r3n5anv5gm56e11mqs7da